RoslinCT

RoslinCT is a prominent Contract Development and Manufacturing Organization (CDMO) that specializes in cell and gene therapies. Founded in 2006 as a spin-out from the Roslin Institute, the company operates from state-of-the-art facilities in the UK and the US, with its headquarters located at Edinburgh BioQuarter. RoslinCT is dedicated to translating advanced cellular biology research into clinical and commercial therapies. The company offers comprehensive services for cell and gene therapy development, including process development, GMP manufacturing, regulatory support, and innovation partnerships. RoslinCT also provides pluripotent stem cell lines and cell-based therapeutic products, leveraging its expertise in cloning technology. It collaborates with biotech and pharmaceutical companies globally, as well as academic institutions, to enhance research and development efforts. With a focus on accelerating the delivery of curative therapies, RoslinCT is committed to bridging the gap between research and commercialization.